Drug intelligence / Profile preview

chaiqin xiaoyongyin

Development stage: Preclinical
Lead developer: Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration: Oral

Overview

Chaiqin Xiaoyongyin is a Traditional Chinese Medicine (TCM) formula, typically administered in granule form. It is being investigated for the treatment of granulomatous lobular mastitis, specifically targeting the 'liver meridian accumulation heat' type of the disease. As a TCM formulation, it is composed of multiple herbal ingredients that are believed to work synergistically to clear heat, detoxify, reduce swelling, and promote circulation, addressing the underlying imbalances according to TCM principles.

Other names: Chaiqin Xiaogan decoction

Beyond the preview

Go deeper on chaiqin xiaoyongyin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on chaiqin xiaoyongyin.

Explore the full profile